EBITDA grew 8% to ₹193 crore. The company’s operating margin narrowed to 22% from 26% a year ago.
The average revenue per operating bed (ARPOB) rose 11.8% year-on-year to ₹43,011, while the average revenue per patient (ARPP) grew 9.8% to ₹1,53,094.
The company reported cash and cash equivalents of ₹70 crore as of the end of the quarter.
B Bhaskar Rao, Chairman and Managing Director, said, “First quarter of FY26 has started on a robust note with all engines performing optimally. Despite being a seasonally lean quarter, we have managed to grow on key parameters. Patient footfalls have seen a good uptick in all units, especially in new ones like Thane. I am optimistic that we are on track to meet our targets for FY26.”
KIMS also highlighted a number of complex clinical cases and milestones across its hospitals during the quarter, including India’s first known use of desensitisation therapy ahead of a cadaveric kidney transplant in Kurnool and the successful treatment of rare pediatric and cardiac cases across its network.
The company’s Bangalore units are expected to commence operations in the second quarter of FY26.
KIMS Hospitals is one of India’s largest corporate healthcare providers, operating a network of 25 hospitals with over 8,000 beds across Telangana, Andhra Pradesh, Maharashtra, Kerala, and Karnataka. It offers multidisciplinary healthcare services focused on tertiary and quaternary care, covering cardiac sciences, oncology, organ transplants, and more.
Shares of KIMS Ltd ended up 0.3% at ₹743.40 on the BSE.
